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ILLICIT OPIATES IN TORONTO: 
A PROFILE OF CURRENT USERS 
BENEDIKT FISCHER~~*,  WENDY MEDVED~, LOUIS GLIKSMAN~~ 
and JURGEN REHMab 
aAddiction Research Foundation, Toronto, bUniversity of Toronto, Toronto and 
'University of Western Ontario, London 
Untreated opiate use remains a significant problem in most jurisdictions. As a precursor to 
developing appropriate treatments and to encouraging these individuals to seek treatment, it 
is essential that the characteristics of this population be understood. The present study was 
designed to serve a number of purposes, one of which was to describe the characteristics of a 
sample of opiate users in Toronto, Canada who were not currently in treatment. One hundred 
fourteen users using opiates regularly who were not in treatment and who were not actively 
seeking treatment were recruited through a variety of techniques and then interviewed. The 
study reports on the demographic characteristics of this sample (age, gender, housing, income 
and income sources), as well as their drug use patterns, health status, previous treatment history 
and other lifestyle issues. The results suggest that the sample is relatively healthy, that most of 
them are users of injectable and prescription opiates as well as other controlled drugs, and that 
their main sources of income were comprised of social benefits and illegal activities. The impli- 
cations of these findings for treatment options and harm reduction policies are discussed. 
Keywords: Opiate use; heroin use; harm reduction; addiction treatment; Canada 
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Blake, and the Toronto "Finally Understanding Narcotics" (FUN) group in the preparation of 
this research project. We would also like to thank Laryssa 'Qson and Lisa Downs for their 
skilled assistance in the preparation of this manuscript. 
BACKGROUND 
Toronto (Canada) is home to an estimated 10,000 - 15,000 illicit opiate 
users, primarily heroin addicts (Southtown Consulting 1995, Fischer and 
Rehm 1997, Remis and Millson 1997). The Toronto opiate and other drug 
scene, unlike that of many urban European drug scenes, is not openly visi- 
ble and locally identifiable but rather dispersed and subterranean, and thus 
* Correspondence Author. 
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378 BENEDIKT FISCHER et al. 
does not qualify as a typical ‘open drug scene’ (see Bless et al. 1994, Vogt 
and Weber, in press). The illicit opiate market takes place in a number of 
different parts of the city, and user populations are typically not concen- 
trated or broadly networked. 
Heroin and opiate use in Canada is governed by the Controlled Drugs 
and Substances Act (CDSA). This recently overhauled law prohibits the 
possession and supply of heroin. These behaviours are dealt with as crimi- 
nal offenses with severe criminal punishment, with simple possession of 
minimal amounts of opiates being punishable by up to 7 years imprison- 
ment (Fischer et al. 1996). In 1995, there were 125 heroin offences in 
Toronto, which constitutes approximately 3% of all drug law arrests made 
in the city. This arrest rate is similar to that of Montreal, QuCbec, but only 
one tenth of the heroin arrest rate in Vancouver, BC (Canadian Centre for 
Justice Statistics 1996). It is currently not possible to systematically profile 
sentencing outcomes for drug possession offenders, distinguishing for dif- 
ferent types of drugs for which the offender had been arrested and charged, 
because the conviction rates by specific drug categories are not provided. 
The number of drug-related deaths per annum, examined by the Toronto 
coroner’s office, in which heroin was identified as one of the contributing 
factors almost doubled from 35 in 1991 to 65 in 1994, and then fell to 45 
in 1995 (latest available data; Metro Toronto Research Group on Drug 
Use, 1996). Services and treatment options for heroin addicts in Metro 
Toronto have traditionally been relatively limited. By the end of 1995, 
there were around 770 methadone treatment spots in all of the province of 
Ontario, with approximately 47 local physicians authorized to provide 
methadone maintenance, two thirds of which were concentrated in the 
Metropolitan Toronto area (Health Canada 1996, Fischer in press). The 
majority of the methadone treatment programs in the City were offered 
through clinical institutions like the Addiction Research Foundation’s Opi- 
ate Clinic or the Parkdale Clinic, with only a few local physicians prescrib- 
ing substitution opiates. Most of these programs, however, were rather 
selective in terms of client recruitment, implemented rigorous client con- 
trol regimes (mandatory urine testing and counselling, daily pick-ups, etc.) 
and were based on abstinence-oriented treatment principles. Due to the 
immense imbalance between demand and supply for methadone treatment 
in the city, waiting lists until recently have traditionally been at capacity, 
and many substitution treatment seekers have been kept on lists for years 
without getting access to methadone treatment. 
A
dd
ic
t R
es
 T
he
or
y 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ita
et
 Z
ue
ric
h 
on
 0
8/
04
/1
4
Fo
r p
er
so
na
l u
se
 o
nl
y.
ILLICIT OPIATES IN TORONTO 379 
Due to some recent changes in the licensing practices of physicians and 
regulations governing the procedures of methadone maintenance programs 
in Ontario, the numbers of physicians licensed for methadone prescription 
as well as maintenance clients in treatment has increased consistently over 
the past couple of years (Fischer in press). However, it should be noted 
that relative to international standards, the number of methadone mainte- 
nance spots per capita in Canada overall is very low - a situation that has 
historically been reflected in Ontario and the city of Toronto specifically. 
In the beginning of 1996, Canada had 107 methadone spots per million 
inhabitants, compared to 2,000 in Switzerland, 1,OOO in Australia, 730 in 
Belgium and even 44 1 in the US (Health Canada 1996). Canada’s injection 
drug use population is, on a per capita level, estimated to be the size of 
Australia’s, slightly smaller than that of the US, and about half the size of 
that of Switzerland (Reuband 1995, Wodak 1992, Nadelmann et al. 1997). 
The differences in the numbers of methadone treatment spots cannot 
solely be explained by smaller demand. 
In terms of needle exchange facilities, the Toronto situation is best illus- 
trated by the following statistics. There are eight needle exchange facilities 
in the city. In 1996, a total of 123,500 sterile needles were given out by the 
city’s needle exchange facilities, which on the average translates to 
slightly over 600 needles per day (Toronto Public Health Department 
1997). These numbers are small when compared with those in other juris- 
dictions: Hamburg (Germany) features an intravenous drug use population 
(IDU) similar in size to Toronto and exchanges over 3 million needles a 
year, Oslo’s (Norway) IDU population is estimated to be half that size, and 
over 600,000 needles are exchanged (Fischer 1995, Bretteville-Jensen and 
Sutton 1996). 
HARMS AND CHARACTERISTICS OF OPIATE USE 
ELSE WHERE 
Illicit opiate use has long been associated with a considerable spectrum of 
health, social and economic harms and problems (Department of Health 
and Human Services 1995, Rettig and Yarmolinsky 1995, Swiss Metha- 
done Report 1996). These harm factors related to opiate use may be, for 
conceptual reasons, divided into two different categories: Actual harm fac- 
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380 BENEDIKT FISCHER et al. 
tors, meaning harm aspects that are evidenced by opiate users, and risk 
factors which are created by higher prevalence of exposures or circum- 
stances that make illicit opiate users more prone or likely eventually to 
incur certain forms of harms. An example of the former category is prop- 
erty crime activity which occurs in conjunction with opiate use. Such 
crime has negative consequences for the individual user and society, and 
should be considered a related form of “harm”. An example of the latter 
category would be possible exposure to communicable infectious diseases 
that eventually may lead to morbidity or mortality. Needle sharing is a risk 
factor which enhances an opiate user’s chances of becoming exposed to 
infectious diseases like hepatitis or HIV, which may then eventually result 
in illness and have related individual and social harms and costs. 
Harm and risk factors must each be investigated from epidemiological, 
intervention and treatment, and also prevention perspectives. However, 
actual harms which are related to opiate use may only be tackled by inter- 
vention, which deals with the harms after they have occurred, while risks 
still leave room for prevention work. To effectively target both aspects of 
intervention, however, it is rather important to understand what the critical 
harm and risk indicators and profiles of a given user population are. In 
general, however, it is important to understand harms and risks associated 
with illicit opiate use in an interactive, multi-dimensional concept of 
agency. Harms materializing with illicit opiate use (like high prevalence of 
crime or unemployment) are rarely directly related to the drug or its user, 
but rather are an indirect outcome of an interactive process between a host, 
an agent and an environment, meaning the opiate user, hisher drug of 
choice and the real life context in which she  operates (Haddon 1980, 
Fischer 1995). Many examples in the context of addiction have shown that 
the simplistic targeting of one of these factors towards change (e.g., 
through the use of drug laws which are suggested to act as a deterrent to 
drug users) frequently does not change the overall “harm” situation signif- 
icantly, and in many cases increases the overall harm and risk situation 
(Fischer et al. 1997). Rather, attempts to influence the interaction and the 
interactive outcomes between these three entities may lead to much more 
significant and efficient ways to reduce the negative aspects associated 
with illicit opiate use. In fact, this philosophy constitutes one of the basic 
tenets of the so-called “harm reduction” paradigm (Drucker 1995, Fuchs 
and Degkwitz 1995, Nadelmann et al. 1997). 
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ILLICIT OPIATES IN TORONTO 38 1 
The harm and risk profile characteristics of illicit opiate users generally 
extend into the following areas of interest (Department of Health and 
Human Services 1995): Demographic and socio-economic; drug use, 
demand and supply; physical and psychological health status and risk fac- 
tors; health and drug treatment variables, and involvement in crime and 
criminal justice system. Importantly, significant differences have been 
found in opiate use populations from different jurisdictions or cultural 
contexts, and opiate use research has also shown substantial shifts in the 
prevalence and nature of opiate-related harms over time. Solid and elabo- 
rate knowledge about the type and prevalence of these aspects is, naturally, 
necessary for appropriate and effective (proactive or reactive) policy inter- 
vention. That is, the high prevalence of property crime or HIV infections 
associated with illicit opiate users in one jurisdiction should ideally trigger 
a different policy and program response than in settings where these harms 
figure relatively substantially lower. 
Thus far, hardly any systematic and research based knowledge has been 
available recently in terms of the harm and risk profiles associated with 
illicit opiate users from the Metropolitan Toronto area. Subsequently, 
many policy, program and service options for illicit opiate users have been 
made on the basis of vague data or secondary estimates (Southtown Con- 
sulting 1995). 
Empirical trends in opiate-use related harms and risks 
As the available research data on un-treated and illicit opiate users else- 
where indicates, the majority of opiate addicts are under 40 years of age, a 
finding which is rational since morbidity and mortality do not allow for 
long opiate use careers (Rettig and Yarmolinsky 1995, Hser 1993). A 
number of studies have suggested that there has been an increase in the 
average age of opiate addicts, with various studies now reporting an aver- 
age population age of 30 years of age (Kemmesies 1996, Buning 1986). 
These studies have also shown that opiate addiction is predominantly a 
male phenomenon, with men outweighing women in survey populations 
by about five to one (Rettig and Yarmolinsky 1995). Numerous opiate 
users report low levels of social functioning, integration and self-sufti- 
ciency. In the user sample entering the Swiss heroin prescription trial, only 
47% of the sample lived in their own housing. Samples of untreated heroin 
users have consistently shown employment levels limited to between 20 
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382 BENEDIKT FISCHER et al. 
and 30% (Maddux and Desmond 1979, Hubbard et al. 1989, Simpson and 
Sells 1982). In the Swiss sample, only 3 1 % of the sample had income from 
employment, while over three quarters received social assistance benefits 
(Uchtenhagen et al. 1995). A recent study from Oslo, Norway, suggests 
that within a large sample of injection drug users in Oslo, more than 4 out 
of 5 users received welfare benefits (Bretteville-Jensen and Sutton 1996). 
Similar results were found by a study on opiate users in Amsterdam (Grap- 
endaal 1992). 
It has been well-documented that due to the circumstances of illicit opi- 
ate markets and the need to regularly buy illicit opiate substances at high 
prices, opiate addicts incur considerable expenses, largely to buy drugs. In 
the majority of cases, these expenses exceed funds and income available 
from legitimate sources (Dorn et al. 1994). As a consequence, many opiate 
addicts resort to illegal (property crime) or semi-legal sources of income 
generation, most of which involve property crime (monetary or goods that 
are turned into income), small-scale drug market activities (buying and 
selling of drugs under net profits) and behaviours like prostitution (in itself 
not an offense in Canada, but with surrounding behaviours defining it as a 
“de facto” crime on a street level). 
While there are widely differing reports on the level of expenses 
incurred by opiate addicts, a number of studies have found similar sources 
of opiate users’ income. Two field studies with addicts in Germany suggest 
that drug addicts spending hundreds of dollars on their drug habits per day 
is a phenomenon of the past (Kreuzer et al. 1991, Kemmesies 1996). This 
is partly due to the fact that illicit drug prices in almost all jurisdictions 
have dropped substantially over the past decade. Both studies suggest that 
average expenses are in the realm of $100 - $150 per day and user, 
although these figures naturally depend on the given market prices for the 
drugs sought and consumed. Other studies, based upon areas with compa- 
rably much higher drug market prices, indicate much higher “cash flow” 
levels among addict users (Bretteville-Jensen and Sutton 1996, Dorn et al. 
1994). These studies have also suggested that welfare benefits, small scale 
drug market activities (dealing) and property crime constitute the main 
sources of income for drug addicts, although there are variations between 
these sources for different socio-cultural environments. 
In terms of drug use, illicit opiate users do not tend to limit themselves 
just to using opiate substances. Opiate user groups report regular or fre- 
quent use of cocaine substances by 40 to 70% of user samples examined 
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ILLICIT OPIATES IN TORONTO 383 
(Department of Health and Human Services 1995, Hubbard et al. 1989, 
Ball and Ross 1991, Kemmesies 1996). In Switzerland, for example, 68% 
of the heroin addicts who were recruited into heroin maintenance indicated 
daily use of cocaine (Uchtenhagen et al. 1995). The relatively high preva- 
lence of alcohol, cannabis and amphetamine use among untreated opiate 
user populations suggests a picture of poly-drug use in which opiates play 
a prominent but not exclusive role, a fact which is often ignored but which 
is rather important when thinking about appropriate and effective interven- 
tions to reduce the harms associated with substance use (also Skretting et 
al. 1993, Rettig and Yarmolinsky 1995). In terms of use patterns, opiate 
addiction is generally characterized by at least daily use of opiates (Simp- 
son and Sells 1982, Hubbard et al. 1989). However, an important change 
has been reported from European opiate user scenes, where many users 
have switched from injection as the primary mode of use to “sniffing” or 
“smoking” (Gossop 1995, Grund 1996, Rehm et al. 1994, Pearson 1987). 
One of the main concerns about illicit opiate use, and intravenous drug use 
in general, is the health status of users, their health risks to themselves, as 
well as the level of health risk of others who interact with the drug user. In 
the Swiss opiate user sample, approximately one quarter were diagnosed 
with a status of “bad physical health”, while 42% were characterized as fea- 
turing a status of “bad mental health”. Forty-seven percent reported chronic 
severe health problems, and 75% of the sample had received two or more 
sessions of in-patient treatment for health problems in the 6 months prior to 
the study (Uchtenhagen et al. 1995). However, it has also been found in 
other jurisdictions that opiate addicts do not use primary or routine medical 
care more often than non-users despite their substantially higher prevalence 
of acute health problems. Contact with the health care system is mostly lim- 
ited to emergency room visits, rendering them a “particularly medically 
under served population” (Rettig and Yarmolinsky 1995:69). In addition to a 
“variety of social and medical problems”, Rettig and Yarmolinsky conclude 
on the basis of the ECA sample that heroin addicts showed a comparative 
“excess of depression and other psychiatric disorders” as well as other “dra- 
matic rates of co-morbidities” ( I  995:69). 
A meta-analysis of opiate user mortality data suggests that the average 
mortality rate for opiate addicts is around 1% to 2% per year (Rehm 1995). 
A unique longitudinal study which followed a cohort of opiate addicts 
from 1964 to 1986 (average age at start was 25.4 yrs.) found that 28% of 
the original sample had died in the years prior to follow-up (Hser et a1 
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384 BENEDIKT FISCHER er al. 
1993). Besides the usual physical health problems, “overdosing” (OD) has 
emerged as a key morbidity and mortality factor among IDUs. For exam- 
ple, 68% of the sample in a recent German IDU study reported an OD at 
least once in their lifetimes, while 23% had experienced an OD event in 
the past month (Kemmesies 1996). The dramatic increase in the number of 
opiate-related overdose deaths in British Columbia through the first half of 
the 1990s reflected a trend that had been experienced in otherjurisdictions 
(Cain 1994, Fischer 1995). 
A key health risk for intravenous drug users is the transmission of infec- 
tious diseases via injection or unsafe sexual contacts. A series of studies on 
IV-opiate users in Zurich reported Hepatitis prevalence rates between 50 
and 75 percent (Uchtenhagen et al. 1995). Much of the attention on the 
infectious disease risks related to IV-drug use has been directed towards 
the HIV virus. Dramatic differences exist with regard to the actual preva- 
lence and sero-conversion rate among intravenous drug users - ranging 
from under 5% to areas with 50-70% (World Bank 1993, WHO 1993, 
Fischer et al. 1997). There is clear evidence that regular IV-drug use is one 
of the strongest predictors of HIV infection at a population level. In some 
jurisdictions, including the US, IDU populations are responsible for the 
majority of new HIV infection cases (Nadelmann et al. 1997, DesJarlais 
1994, DesJarlais et al. 1994). A comparative sample study of former illicit 
injection opiate users versus continuing users over a 3-year period showed 
that the latter are significantly more likely to contract HIV (Metzger et al. 
1993, see also Rettig and Yarmolinsky 1995). The enormous public rele- 
vance of rates and risk patterns with respect to infectious diseases among 
IDUs is also underlined by the fact that a considerable number engage in 
prostitution to generate income (Skretting 1992). 
In Canada, the available evidence on HIV rates among intravenous drug 
users shows a dramatically diversified picture. While recent studies in 
Toronto have indicated HIV positive rate levels of under lo%, Montreal’s 
rates seem to lie in the 20% range, while Vancouver reports a recent explo- 
sion in HIV infections with rates in the IDU population reported to be 25% 
and higher (Millson 1996, Health Canada 1997). The overall positive impact 
of needle exchange programs on containing infection prevalence rates as 
well the reduction of needle sharing events has been well documented (Lurie 
and Reingold 1993, Nadelmann et al. 1997). However, there are still knowl- 
edge gaps with regards to the impact of availability and use of needle 
exchange facilities on individual IDU’s risk patterns over time. 
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ILLICIT OPIATES IN TORONTO 385 
A series of large-scale studies with opiate addicts entering treatment pro- 
grams compiled in the US around 1990 suggested that user populations are 
generally rather heterogeneous in terms of their drug treatment histories. 
The American National AIDS Demonstration Research (NADR) sample 
reported that roughly one third of the sample had never been in drug treat- 
ment, one third had some non-methadone treatment, and the remaining 
third had been in methadone treatment before. The Drug Use Forcasting 
(DUF) study indicated that almost two thirds did not have any drug treat- 
ment history at all (Rettig and Yarmolinsky 1995:73ff, Flynn et al. 1994). 
Similar, less recent overviews as well as a survey of opiate treatment cli- 
ents in 26 American states, reported that between 36 and 44% of the sam- 
ples reported three or more prior treatment attempts (Flynn et al. 1994, 
Client Data Survey in: Rettig and Yarmolinsky 1995, Simpson et a1 1986). 
There is no debate over the fact that most illicit, regular opiate use is 
connected with criminal activity, as established by numerous extensive 
studies (for good overviews see Johnson et al. 1985, Faupel and Klockars 
1987, Hammersley et al. 1989). Crime associated with opiate use falls into 
two general categories; "drug crime", the violation of drug laws through 
the possession or dealing activities involving illegal substances, and 
"drug-related crime", largely property crime to provide money or valua- 
bles to allow the addict to buy drugs (Tonry and Wilson 1990, Collins et a1 
1984, Ball et a1 1981). While both types of crime, and the response to them 
by local criminal justice systems, have substantial implications for the social 
costs of illicit opiate use and its legal control, drug-related property crime 
has direct and substantial negative impact on property, safety and general 
quality of life for the social environments in which illicit drug use occurs. 
An important point in terms of harm and social cost associated with 
illicit drug use, of course, is the source of income for the user. In the Oslo 
study, 27% of addicts reported involvement in property crime, while 43% 
were involved in drug dealing and 20% of the overall sample (50% of 
females) were involved in prostitution (Bretteville-Jensen and Sutton 
1996). However, major differences have been reported across systems. 
While illegal drug market activities constitute 57% of drug user income in 
Oslo and a similar rate of 56% in a Glasgow study, opiate users in Amster- 
dam generated only 20% of their incomes through drug dealing activities. 
The share of overall income acquired through other property crime activi- 
ties is about 33% in Glasgow, and 24% in Amsterdam respectively (ibid., 
Hammersley et a1 1989, Grapendaal 1992). Generally, the role of illicit 
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activities in income generation among illicit opiate users for the Amster- 
dam sample is considered relatively low for European contexts (Dom et al. 
1994), and numbers are generally estimated to be substantially higher in 
North American contexts. Grapendaal et al. (1992) have suggested that a 
negative correlation exists between the extensiveness of welfare systems 
and the share and relative role of criminal activity for income generation 
by illicit opiate users in national contexts; that is, the more developed the 
welfare system, the lower the crime rate. 
The majority (between 50% and 80%) of property-related crime in Euro- 
pean and Australian states is drug related (Kilias and Uchtenhagen 1996, 
Grapendaal et a1 1995, Kreuzer et al. 1991, Parliamentary Joint Committee 
1989). Numerous field studies of addict lifestyles suggest that untreated 
opiate users, on average, have 12 to 22 criminal activity days per month 
(Ball et al. 1983, Ball and Ross 1991, Powers and Anglin 1993, Ball and 
Greberman 1994, Simpson et al. 1995, Department of Health and Human 
Services 1995). Large-scale analyses of opiate user clients admitted to 
treatment programs in the US suggest that at least between one third and 
half of the admissions had engaged in regular criminal activity prior to 
treatment (Sampson et al. in: Rettig and Yarmolinsky 1995, Flynn et al. 
1994). However, other self-report studies suggest that while some opiate 
users engage either in drug (supply) crime or property crime to support 
their drug habits, others do not or do so only at minimal levels, and that 
these differences may be connected to social support and assistance struc- 
tures available to addicted users (Grapendaal 1992, Bretteville-Jensen and 
Sutton 1996, Kemmesies 1996). 
It has also been suggested that the amount of opiate substances con- 
sumed and the frequency and prevalence of drug-related crimes committed 
by the user are correlated. However, the direction of causality is not clear 
(Hammersley et al. 1989, Johnson et al. 1985, Faupel 1981, Nurco et a1 
1985). Due to the high frequency and prevalence of criminal activity 
among opiate addicts, and in the persistence with regards to these activi- 
ties, the majority of addicts have had multiple arrest, criminal conviction 
and incarceration histories, all of which incur massive social costs (Single 
et al. 1996). In the Swiss heroin user sample, 86% had been criminally 
convicted at least once, while over one third had been convicted at least 
three times. Over half of the sample had served jail time since the onset of 
opiate use (Uchtenhagen et al. 1995). The large-scale analysis of American 
opiate addict samples reported an incarceration history for 60 to 80% of 
the populations examined (Hubbard et al. 1989, Flynn et al. 1994). 
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CONTEXT AND PARAMETERS OF THE STUDY 
Our “harm and social cost of untreated opiate use” study -known under 
its street name as the “Smack Study”- was conceptualized to serve two 
main research functions. 
First, it is an examination of the scope, parameters and characteristics of 
illicit opiate use in Metro Toronto. As such, it allows for an account of the 
harms and social costs associated with untreated opiate use, and thus pro- 
vides the necessary knowledge base to allow us to design and improve 
possible interventions, services and harm reduction strategies for this 
problem area. The study was designed to have an initial baseline measure 
and then a follow-up measure after one year, This follow-up measure will 
allow us to examine changes in drug use patterns and related behaviours 
among an untreated population over time. 
Second, the study is an integral element in a much larger treatment eval- 
uation study which assesses the efficacy and cost-effectiveness of a 
number of methadone programs in Toronto, including a recently 
revamped, “lower threshold” methadone program at the Addiction 
Research Foundation in Toronto. This evaluation study will use the data 
described in this paper as a baseline comparison measure for the ongoing 
efficacy and cost-effectiveness investigation of some of the methadone 
maintenance programs in existence in Toronto. It will also help us deter- 
mine what the fundamental differences are between opiate users who end 
up in methadone programs versus those who do not. As well, it will help 
us determine what impacts and harms, associated with illicit opiate use, 
our methadone programs are capable of altering or reducing in the specific 
Toronto context. 
As its key study areas, this investigation focuses on the following char- 
acteristics of this drug-using population: Demographics, socio-economic 
circumstances, physical and mental health, drug (opiates and other) use 
prevalence, patterns of use ar.d related harms, sex-related risks, drug use 
related risks to self and others, health care and treatment system issues, 
criminal activities and criminal justice system involvement. This paper 
reports on data gathered and analysed from the first, the baseline, round of 
interviews with the study sample. 
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388 BENEDIKT FISCHER et al. 
METHOD 
Ideally, a representative sample of untreated current opiate users in Metro 
Toronto would be the basis of the current study. However, as opiate users 
constitute a “hidden population”, such a sample is impossible to create, 
since no population exists from which to draw probability samples (Spreen 
1992, Spreen and Zwagstra 1994, Kubler and Hausser 1997). Since only 
probability samples guarantee representativeness in the statistical sense 
(Levy and Lemeshow 1991), the current sample cannot be considered to 
be representative of all untreated opiate users in Toronto. Different altema- 
tives have been developed to overcome this problem, and to approach at 
least some basic characteristics of representativeness (e.g. Watters and 
Biemacki 1989, Hartnoll et al. 1995, Kubler and Hausser 1997). We have 
made use of some of these approaches, specifically, a targeted recruitment 
campaign and a snowball referral campaign. We hope that the two meth- 
ods together will help us to attain a sample of typical Metro Toronto opiate 
users without claiming representativeness in a strict sense. 
The subject recruitment period for the study was June 1996 to March 
1997. As its main method of recruitment, the study relied on an advertising 
campaign to enlist subjects. A few thousand handouts about the study were 
distributed at a number of identified key contact points for opiate and other 
drug users in Metro Toronto. The flyer outlined the basic scope, proce- 
dures and eligibility requirements of the study, ensured confidentiality and 
anonymity, indicated the renumeration for study subjects (CDN$ 25 for 
the baseline interview), and offered a telephone number to call for further 
information. The handout was made available at most of the needle 
exchange facilities, local public health offices and a variety of drop-in cen- 
tres for opiate and other drug users in Metro Toronto (see below for a dis- 
cussion of the key implications for sampling). A few ads featuring the 
same text were run in established city and “scene”-type of weekly or 
monthly publications. 
The second recruitment technique utilized a variant of the “snowball” 
method, in which subjects who were accepted for the study were asked to 
contact friends and acquaintances who fit the criteria and were interested 
in participating in the study. 
The study established its own telephone call-in line, where interested 
potential subjects called and indicated their general interest in participat- 
ing. After being told what the study was all about, and again securing their 
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lLLIClT OPIATES IN TORONTO 389 
interest, they were then screened for study eligibility. Two main eligibility 
criteria for the study were utilized. First, the study only accepted people 
who were “regular” users of heroin and other opiates, where “regular” use 
was operationalized as at least daily use over the past week. Second, the 
study required the subjects to currently not be in treatment, and to not have 
sought treatment in the three months prior to screening. For ethical rea- 
sons, pregnant women were also excluded from the study. The telephone 
screening also tried to establish the authenticity of the subjects’ informa- 
tion regarding their heroin use by asking about previous treatment histo- 
ries, attempts to quit opiate use, and experiences with withdrawal 
symptoms. People who were deemed to be eligible for the study were 
invited to take part in a one-on-one interview. 
The interviews were held in a variety of locations across the city, largely 
in spaces provided by the facilities that had assisted in the study recruit- 
ment campaign. The frequency and distribution of reply calls vaned sub- 
stantially, with some weeks being extremely busy (25 calls or more) and 
others being rather slow (5 calls or less). Approximately 75% of the inter- 
view appointments were kept. There were a number of attempts by sub- 
jects to “double dip,” that is, for subjects to try to be interviewed twice in 
order to collect the fee a second time, which were detected and excluded 
by the investigators. An average of 4-5 interviews were held per week. 
The interviews which provided the data presented below were conducted 
between June 1996 and April 1997. 
After meeting the interview subject and again going through a summary 
of the basic parameters and objectives of the study, the interviewee was 
given a consent form for the interview. This form would, among other 
things, outline the confidentiality of the data, and guarantee anonymity. 
The consent form also expressed the investigator’s interest in conducting a 
follow-up interview in one year with the same data items, and that the 
same recruitment methods would be used to re-recruit study subjects. That 
is, flyers would be used to remind subjects to call in for their follow-up 
interview and the snowball variant whereby interviewees would be asked 
to tell friends that it was time to be re-interviewed. In order to ensure ano- 
nymity as well as data linkage at follow-up, the study used a subject code 
that consisted of the subject’s mother’s first name in combination with the 
day arid month of the subject’s date of birth. 
The data collection itself occurred via a 60-90 minute face-to-face inter- 
view, utilizing a mix of some 140 quantitative and qualitative questions. 
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390 BENEDIKT FISCHER et al. 
The basic categories which the items measured included demographics, 
social and economic parameters, physical and mental health issues, health 
and drug treatment systems experiences, indicators of drug use, patterns 
and harms, sex and drug-use related risks to self and others as well as 
legal, criminal activities and criminal justice cost issues. 
The study trained two interviewers with background in interviewing 
practices who conducted the pilot testing. The interviews were conducted 
by one (female) interviewer. Based upon feedback from an opiate user 
group, revisions were made to the questionnaire while the study was under 
way. These revisions resulted in some changed or added questions, which 
resulted in sample size variations for different study items. 
STUDY RESULTS 
Demographic and socio-economic data 
By April 1997, a total of 114 subjects had been interviewed in this Toronto 
study sample. Four out of five subjects (81.6%) were male. 
In terms of age, the sample did not include any opiate users under the 
age of 20. Fifteen percent of the sample were between twenty and thirty 
years of age. Over half of the sample (55.3%) were in their thirties, while 
about one third (29.8%) were older than 40. This age distribution, with rel- 
atively few subjects in the “under 30” category, seems to confirm the pat- 
tern found elsewhere, in which the population of opiate users generally 
seems to be older than those of other illicit drug using populations. 
More than half (5 1.8%) of the sample indicated that they currently live in a 
rooming house, shelter, hotel, temporarily at someone else’s place, or on the 
street or with no fixed address at all. The other half live in leased accomoda- 
tion or with family. Almost one out of ten subjects in this sample have chil- 
dren under 18 years of age for whom they are responsible. Almost three 
quarters of the sample (72.6%) reported that they currently live with at least 
one other person, and of those who live with another person, the majority 
lived with friends or roommates in a shared accomodation setting, while 
some lived with their spouse, partner or family. In almost all (86.9%) of the 
cases in which the subjects lived with others, people in the environment in 
which the user was living were aware of their opiate use, and in 63.9% of 
the cases the person with whom the respondent was living, was also an 
opiate user. 
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ILLICIT OPIATES IN TORONTO 39 1 
TABLE I Socio-Demographic Characteristics of Total Opiate User Sample, 1996 (N = 114) 
Demographic Characteristic f N )  % 
Sex 
Male 93 81.6 
Female 21 18.4 
Age 
< 20 
21 -30 
31 -40 
41 -50 
0 0.0 
7 14.9 
63 55.3 
31 21.2 
51 + 3 2.6 
Living Conditions 
Permanent dwelling: 
Own /rent / live in parent’s home 
Temporary dwelling: 
Shelter / rooming house /hotel / n o  fixed address / street 
Persons who currently live: (N = 84) 
Alone 
Spouse or partner 
Parent or sibling 
Friend 
Other residents 
Children 
(Multiple answers possible) 
55 48.2 
59 51.8 
23 27.4 
13 15.5 
10 11.9 
12 14.3 
29 34.5 
4 4.8 
Children 
Persons currently responsible for children under age I8 10 9.4 
(N = 106) 
Employment 
Persons who engaged in paid work in last 12 months 61 53.5 
Persons currently doing paid work 19 16.7 
I .  All percentages refer to the total sample of N = 114, unless otherwise indicated in the left 
column. 
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In terms of employment, slightly more than half (53.5%) of the sample 
had engaged in some sort of paid work in the 12 months prior to the inter- 
view, although more than four fifths (83.3%) of the sample were not 
employed at the time of interview. Of the ones who were employed at the 
time of the interview (16.7%), only a minority (38.9%) worked at a steady, 
full-time job. Of the ones who did engage in any paid work in the past 
12 months, more than half (60.4%) worked six months or less (overall 
mean: 23.3 weeks). In addition, more than half of the respondents (55.3%) 
indicated that they would have liked to have had more paid work in the last 
12 months. 
TABLE I1 Income and Income Sources Over Last 30 Days Among Total Opiate User Sample, 
1996 (N = 114) 
(N) % AVGamount SDinCDN$ 
in CDN $ 
Income 
Average total income for last 30 days 114 - $2,238 $ 1,764 
Income Sources 
Money acquired through each income source in last 30 days: 
Social Benefits 86 75.4 579 353 
Illegal Activities 77 67.5 1.432 1,340 
Gift / Loan 56 49.1 842 1,386 
Job / Employment 35 30.7 1.065 1.093 
Prostitution 11 9.6 2.41 I 2.147 
The mean total income for respondents for the 30 days prior to the inter- 
view was estimated to be $2,238. This included revenue from a variety of 
sources and was confirmed by a separate question which asked respond- 
ents to estimate their monthly living expenses, including drugs. 
Respondents listed the following sources that they utilized to generate 
their incomes: 1. Social benefits (75.4%), 2. illegal activities (67.5%), 3. 
gifts and loans from family and friends (49.1 %), 4. employment and work 
(30.7%), and 5. prostitution (9.6%). As the list of average monthly 
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incomes from the different sources shows, the incomes from prostitution 
and illegal activities are the most significant in terms of the amount of rev- 
enue they generate. Considering the percentage of the sample that engages 
in illegal activities for income generation, these are the most significant 
income sources for the opiate user sample examined. The data also show 
that most receive welfare benefits, with the average amount received being 
close to the current maximum welfare benefit amount in Ontario (currently 
stands at CDN$520. - per single persodmonth). The amount of gifts and 
loans received is almost as high as the average income from employment. 
Of those who were asked if there were any sources of income or means 
to acquire drug money that they would eliminate (e.g., criminal activities 
or prostitution) if they had sufficient access to their drug of choice, 75.0% 
of the overall respondents said yes. 
Drug/Opiate use profile 
Almost the total sample of opiate users interviewed (97.4%) used drugs 
other than opiates in the 30 days prior to the interview. Table 111 indicates 
that the majority of the sample had been using benzodiazepines as well as 
cocaine over the past 30 days; a finding that is consistent with other opiate 
user samples. Crack use is prevalent with about one third of the sample. 
The use of recreational drugs (alcohol and cannabis) is also prevalent with 
the majority of the sample. 
In terms of heroin use, the mean age of first use of heroin in this sample 
was in the early twenties, although 17.3% of the sample indicated that they 
had used heroin for the first time when they were 16 or younger. On aver- 
age, this group had used heroin for a period of 10 years. Overall, almost 
two thirds of the heroin using sample (61.5%) had been using heroin for 
less than ten years, with somewhat over one third having used heroin for 
5 years or less. A quarter of the sample (25.3%) had been using heroin on 
a regular basis for a period of 15 years or more. 
Almost the entire sample (92.1 %) had used heroin as their opiate drug of 
choice in the past 30 days. Of the heroin users, 14.3% had taken it infre- 
quently in the past month, up to a maximum of 2-3 times per week. Seven 
out often heroin users (70.5%) used heroin at least once per day, with the 
majority of these taking it 2-3 times per day. Only some respondents indi- 
cated that they use it either only once a day, or 4 or more times day. 
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394 BENEDIKT FISCHER et al. 
TABLE 111 Drug Consumption Patterns of Total Opiate User Sample in Last 30 Days, 1996 
( N =  114) 
(N) % 
Prevalence of Opiate Use I I4 100.0 
Heroin 105 92. I 
Other Opiates 83 72.8 
Prevalence of Other Drug Use 
Alcohol 
Cannabis 
Benzodiazepines 
Cocaine 
1 1 1  97.4 
80 70.2 
13 64.0 
69 60.5 
66 57.9 
Crack 38 33.3 
Barbiturates 15 13.2 
Methadone 7 6. I 
Amphetamines 5 4.4 
Two thirds of the sample (66.3%) indicated that per single use of heroin, 
they used between 1/20 and 1/10 of a gram. Almost a quarter of the heroin 
users reported that they usually take a quarter of a gram of heroin or more per 
single use occasion. In terms of amounts for daily use, the largest number of 
users used between a quarter and halfa gram. About one third used less than a 
quarter gram, while the remainder of the sample used more than half a gram - 
some of them, in fact, more than one gram per 24 hour period. 
The majority (86.4%) of heroin users listed IV injection as their primary 
mode of use, while 8.7% listed snorting and 4.9% smoking. A vast major- 
ity of them (79.8%) used heroin or other opiates regularly in combination 
with other drugs. Over half of those (57.1%) are primarily using heroin or 
opiates in combination with cocaine or crack. 
Three quarters of the total sample had consumed opiates other than her- 
oin in the past 30 days. While opiate use is much less frequent than heroin 
use, the most prevalent opiate drugs listed were Percodan and Tylenol (T3, 
T4) with codeine content. Both the average age of first use as well as aver- 
age length of regular use of other opiates show values similar to those for 
heroin. The majority of users in the sample use other opiates on a less than 
daily basis, with only about one quarter of the user sample taking other 
opiates multiple times per day. 
. 
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ILLICIT OPIATES IN TORONTO 395 
TABLE IV Prevalence and Frequency of Heroin Use Among Sample Using Heroin, 1996 
(N = 114) 
( N )  % 
Prevalence of heroin use in lifetime 110 96.5 
Length of Use 
Persons who have used heroin on a regular basis in 
their lifetime 
Number of years of regular use (N = 91 ) 
< I  
1 - 5  
6 -10 
I I  - 15 
16-20 
21 + 
Prevalence of use in last 30 days (N = I 10) 
Frequency of use in last 30 days (N = 105) 
Once per week or less 
2 - 6 x per week 
Once per day 
2 - 3 x per day 
21 + x per day 
Average amount per single use in last 30 days (N = 80) 
Half - one tenth 
Tenth and a half - two tenths 
Quarter gram or more 
Average amount per daily use in last 30 days (N = 85) 
Less than quarter gram 
Quarter - half gram 
Over half a gram - one gram 
More than one gram 
Average age at first use (N = I 10) 
91 82.7 
2 2.2 
33 36.3 
25 27.5 
10 11.0 
9 9.9 
12 13.2 
105 95.5 
10 9.5 
21 20.0 
15 14.3 
45 42.9 
14 13.3 
53 66.3 
9 11.3 
I8 22.5 
30 35.3 
39 45.9 
13 15.3 
3 3.5 
AVG (years) SD (years) 
21.8 6.0 
Number of years of regular use (N = 9 I )  10.0 8.5 
Over four fifths of the total sample (83.2%) considered their drug use, 
whether opiates or other drugs, to be a problem for themselves. Three 
quarters (75.5%) ofthe sample of opiate users listed heroin as the most 
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problematic drug for themselves, while 8.5% listed other opiates, and 
8.5% suggested that crack or cocaine was most problematic. Almost three 
quarters of the sample (74.7%) said that they used other drugs to minimize 
or eliminate the withdrawal effects from opiates. Of those, the drugs that 
were listed as being most used for such purposes were other opiates 
(53.6%), benzodiazepines (50.0%) and alcohol (25.0%). 
When asked about their perceptions about their future drug use, 11.6% 
of the sample said that they will likely use more drugs in the future, 17.9% 
said that they would continue using approximately the way they do now, 
54.5% said that they would like to continue to use in some reduced form or 
pattern, and 16.1% said that they would like to quit totally. 
Drug market activities 
Heroin users were asked about the prices that they paid for different 
amounts of heroin on the street. They reported mean costs of about $70 for 
a quarter gram, $130 for a half gram, and $229 for one gram. Of those who 
bought heroin in the past 30 days, the mean number of times they engaged 
in buying heroin in that period was high (38.8 times), and indicated that 
they on average bought more than once per day. More than half of the buy- 
ers (55.7%) indicated that they generally buy between a tenth and a quarter 
gram per purchase, while 34.2% indicated that they usually buy half a 
gram or more per single purchase occasion. The sample of heroin buyers 
reported that they bought a mean amount of 18.3 grams of heroin in the 
past 30 days. On average, they reported having spent a mean (gross) 
amount of $3,133 for heroin purchases in the past 30 days (this amount 
does not take into account their revenue returns for re-selling the heroin). 
In terms of other opiate purchases, half the sample (49.5%) indicated 
that they had bought opiates other than heroin in the past 30 days, that they 
did so a mean number of 12.5 times, and spent a mean amount of $7 1 1 on 
these substances. The sample reported that they spent a mean amount of 
$477 on illegal drugs other than opiates in the past 30 days. 
Close to half the people (46.5%) who had engaged in buying heroin in the 
past 30 days indicated that they also engaged in heroin selling activities in 
the past month. On average, they sold almost half of the heroin (42.2%) they 
had originally purchased. Over three quarters of users (76.9%) said that they 
shared or gave away some of the heroin they bought in the past month. 
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TABLE V Prevalence and Frequency of Opiate Use Among Sample Using Other Opiates 
Apart From Heroin, 1996 (N = 114) 
f N) % 
Prevalence of opiate use in lifetime 110 96.5 
Length of Use 
Persons who have used other opiates on a regular 
basis in their lifetime (N = 110) 
Number of years of use (N = 72) 
< 1  
1 - 5  
6 -  10 
I I  - 15 
16-20 
21 + 
Prevalence of use in last 30 days (N = I 10) 
Opiates most frequently used in last 30 days (N = 83) 
Oxycodone 
Codeine 
Morphine 
Dilaudid 
Frequency of use in last 30 days (N = 83) 
Once per week or less 
2 - 6 x per week 
Once per day 
2 - 3 x per day 
4 + x per day 
Average age at first use (N = I 10) 
Number of years of regular use (N = 76) 
72 
5 
20 
14 
8 
11 
14 
83 
41 
30 
22 
17 
25 
23 
12 
14 
9 
AVG (years) 
65.5 
6.9 
27.8 
19.4 
11 .1  
15.3 
19.4 
15.5 
49.4 
36. I 
26.5 
20.5 
30. I 
27.7 
14.5 
16.9 
10.8 
SD (years) 
20.8 6.4 
12.2 9.8 
Physicians were reported to be another important source of opiate drugs, 
with 39.5% of the opiate user sample having seen a doctor in the past 
30 days to get a prescription for opiate substances. Those who reported 
having seen a doctor to get an opiate prescription, visited 2.2 different doc- 
tors, had done so on average 3.3 times in the last month, and received a 
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mean number of 3.3 prescriptions. Almost half (48.0%) of those who had 
received any opiate prescriptions sold part of the opiates that they had 
received, and 59.1 % gave away or shared some of them. 
When asked about their usual means of testing the quality and strength 
of the heroin that they buy on the street, 52.4% of heroin users suggest that 
they use sensory perception means, 33.0% use a small amount of the opi- 
ate substance they bought before they purchase the full amount, and 38.8% 
state that they trust their dealer in terms of substance quality. 
TABLE VI Purchasing Habits of Opiate User Sample Who Bought Heroin in Last 30 Days, 
1996 (N = 114) 
Drug Market Activities AVG SD 
Average price paid for quarter gram of heroin - CDN $ (N = 92) 
Average number of times users bought heroin in last 30 days 
(N = 101) 
Average amount of heroin users bought per purchase in last 30 days: 
(N = 79) 
Half a tenth - two tenths 
Quarter - half a gram 
More than half a gram 
Average number of grams heroin users bought in total over the last 
30 days (N = 94) 
Average amount of money spent on heroin in last 30 days - CDN $ 
( N  = 94) 
Persons who sold a portion of heroin they bought in last 30 days 
(N = 101) 
Persons who shared or gave away a portion of heroin they bought in 
last 30 days (N = 65) 
$70 
38.8 
25 
36 
18 
18.3 
$3,133 
(N) 
47 
50 
$58 
48.5 
31.6 
45.6 
22.8 
30.3 
$3,862 
% 
46.5 
76.9 
Health and health risks 
The study also investigated indicators of general and drug-specific health 
problems and health risks experienced by this sample. More than half 
(54.4%) of the study sample reported that they are currently experiencing 
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some severe health problems, with one third of the total sample having been 
hospitalized in the past 12 months. Those who were hospitalized spent an 
average of 17.8 days in hospital. Almost two thirds of the study sample used 
emergency services for medical problems at least once in the past 
12 months. Of those who received emergency medical services, the mean 
number of occasions on which such services were utilized was 4.2 times. 
TABLE VII Physical Health Status of Total Opiate User Sample. 1996 ( N  = 114) 
(N! % 
Physical Health Problems 
Persons who currently have health problems 
Persons who experienced a situation in the last 12 months where they 
thought they should seek medical help but decided not to (N = 95) 
Hospitalization 
Persons hospitalized in last 12 months 
Average number of days hospitalized in last I2 months (N = 38) 
AVG 17.8 
SD 29.0 
Emergency Services 
Persons who used emergency services in last 12 months 
Average number of times persons went to emergency in last 12 months 
( N  = 71) 
AVG 4.2 
SD 8. I 
Physician Visits 
Persons who saw physician in  hisher office or clinic in last 12 months 
Average number of times persons saw physician in hisher office or 
clinic in last 12 months (N = 90) 
AVG 23.7 
SD 56.5 
Overdose Experiences 
Persons who overdosed on opiates: 
(N = 98) Lifetime 
last month 
Persons who have never received medical treatment for any of their 
oDiate overdoses (N = 48) 
62 
39 
38 
71 
90 
49 
4 
16 
54.4 
41.1 
33.3 
62.3 
78.9 
50.0 
4.1 
33.3 
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400 BENEDIKT FISCHER et al. 
Three quarters of the sample indicated that they have a regular physician 
or health care provider that they see for medical problems, and slightly 
over half (53.9%) indicated that their doctor was aware of their drug use 
habit. About 4 out of 5 (78.9%) people indicated that they had seen a phy- 
sician at least once for a medical problem in the past 12 months. Of those, 
the mean number of visits was 23.7 for that time period. In spite of this fre- 
quent use of physicians, 41.1 % indicated that there had been at least one 
situation in the past year in which they should have sought medical help 
and did not. 
Half the sample had experienced at least one opiate overdose (OD) 
incident in their lifetime, and almost one out of ten had overdosed in the 
past month. Of those who had overdosed at some point in their lives, the 
mean number of OD incidents experienced was 5.3. One third of the opi- 
ate users who had ever overdosed reported that they had never received 
any medical treatment for these incidents. This sub-sample also indi- 
cated that they had received medical help for a mean number of 3.0 OD 
incidents in their lifetime. 
TABLE VlIl Mental Health Status of Total Opiate User Sample, 1996 (N = 114) 
Last 30 Days Lifetime 
(N) % (N) % 
Mental Health Indications 
Serious depression 
Sericus anxiety or tension 
Hallucinations 
Difficulty understanding, concentrating or remem- 
bering 
Trouble controlling violent behaviour 
Serious thoughts of suicide 
Attempted suicide 
Used dugs of choise to try to commit suicide 
(N = 93.94) 
Prescribed medication for a mental health problem 
65 57.0 93 81.6 
84 73.7 97 85.1 
14 12.3 46 40.4 
63 55.3 81 71.1 
20 17.5 54 47.4 
18 15.8 65 57.0 
3 2.6 36 31.6 
3 3.2 23 24.5 
16 14.0 45 39.5 
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ILLICIT OPIATES IN TORONTO 40 1 
Over one third (36.4%) of the sample indicated that they currently 
have concerns about their mental health, and 11.4% of the sample indi- 
cated that they had seen a physician for mental health problems in the 
past 12 months. 14.0% of the sample had been prescribed medication for 
a mental health problem in  the past 30 days. For those who did see a 
physician for mental health problems, the mean number of visits was 18 
for that period. 
From a list of standard mental health concern issues, half (50.9%) of 
the respondents indicated that they had experienced three or more such 
indicators during the last 30 days. Anxiety and tension, symptoms of 
depression as well as memory or concentration difficulties are prevalent 
with the majority of opiate users in the past month. Over 18 subjects 
indicated that they had had thoughts of suicide in the past 30 days, while 
3 people had actually tried to commit suicide in that period. All these 
mental health indicators show greatly increased rates when looking at 
lifetime prevalence. For example, almost one third of the sample had 
attempted to commit suicide at some point in their lives, and 54.4% of 
the sample indicated that they see their mental health concerns as being 
related to their drug use. 
Almost the entire sample, with just a few single exceptions, had used a 
needle at some point in their lives to inject a drug. Of those who have 
injected, more than nine of ten people (93.0%) had done so in the past 
year. Over seven out often opiate users (70.2%) from this sample currently 
inject drugs using a needle at least once or more times per day. 
Of those who use needles to inject drugs, most indicated that they either 
“almost always” (41 .O%) or “always” (52.0%) use a new needle when they 
inject, and 56.9% indicated that they “always” use a clean spoon. Two 
thirds of current injectors (66.7%) said that they have ever shared a needle 
with someone, and 33.3% indicate that they had done so in the past year. 
Half of those who had been sharing a needle in the past year reported that 
it had happened more than half a dozen times in that period. An even 
larger number reported that they had shared other works with someone in 
the past year. Of those who shared a needle in the past 12 months, exactly 
half said that they had done so less than half a dozen times in that period. 
However, 28.1 % of those said that it happened once a month or more fre- 
quently. 
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402 BENEDIKT FISCHER er ul. 
TABLE IX Needle Use Habits of Opiate User Sample Who Inject Drugs, 1996 (N = 114) 
Injection Drug Use History 
Persons who have injected any drug: 
lifetime 
last year 
last month 
Persons who on average injected a drug one or more times per 
day in the last 12 months (N = 106) 
Location of Injection 
Persons who injected a drug within the last 30 days in the 
following locations: (N = 106) 
Own home 
Someone else’s home 
Public bathroom 
Car 
Street or alley 
Stairwell or hallway 
Abandoned building 
Park or playground 
Crack or speed House I shooting gallery 
Needle Sharing Practices 
Persons who report that they “always” use a new sterile needle 
when they inject (N = 100) 
Persons who have shared a needle: 
(N = 105) lifetime 
last year 
Persons who have shared other works: 
(N = 73) lifetime 
last year 
111 
I06 
96 
80 
77 
70 
49 
37 
26 
22 
I I  
10 
6 
52 
70 
35 
55 
30 
97.4 
93.0 
84.2 
15.5 
72.6 
66.0 
46.2 
34.9 
24.5 
20.8 
10.4 
9.4 
5.7 
52.0 
66.7 
33.3 
75.3 
41.1 
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ILLICIT OPIATES IN TORONTO 403 
Nearly all (93.3%) of those who inject drugs reported that they had 
acquired sterile needles in the past month, and more than four out of five 
(82.7%) had acquired 30 needles or more in that period. The mean number 
of needles acquired by the sample in the past month was 147.2 needles. 
Almost three quarters (74.5%) reported that at the time of the interview 
they held at least one sterile needle, and of these, the majority (59.0%) said 
that they had ten or more clean needles. More than four out of ten people 
(44.8%) said that they currently had the “ideal” number of needles. 
In terms of injection habits, over half the sample (52.4%) indicated that 
they injected drugs either “always” alone or “more often alone than with 
someone”. Considerably less (22.9%) said that they used their drugs more 
often together with someone than alone, and a similar percentage (2 I .9%) 
used them “always” with someone else. For nine out often injectors, the 
ideal place to inject was their own home or somebody else’s home. Almost 
three quarters (72.6%) of the injector sample had actually injected in their 
own home in the month prior to the interview, while two thirds (66.0%) 
had also injected in someone else’s home. Considerable parts of this sam- 
ple indicated that they had injected in a public bathroom, in a car, or in a 
hallway or stairway over the course of the month prior to the interview. 
More than half (55.8%) of the sample reported that they had had unsafe 
sex in the year prior to the interview (“Unsafe sex” in the study was 
defined as “having vaginal or anal intercourse without using a latex con- 
dom or dental dam, or performing oral sex on a man to ejaculation without 
using a condom”). Of those who had unsafe sex, almost one third (3 1.7%) 
indicated that they had had unsafe sex with two or more different partners 
in the past year, and more than half (55.6%) of these people also suggested 
that they had done so at least once a week or more frequently. Most 
(81.3%) of the sample actually believe that their opiate use had a direct 
effect on their sexual practices. The majority of these effects were nega- 
tive, with over half of the respondents suggesting that the opiate use 
resulted in a lack of interest in sexual activities. 
Of those asked the question, more than nine out of ten (92.6%) reported 
that they had been tested for at least one type of existing Hepatitis stream, 
and 27.5% of those tested proved to be positive for HepB, while 55.7% 
proved to be HepC positive. More than four fifths (89.9%) of the sample 
examined had been tested for HIV at some point. Two-thirds (67.7%) had 
been tested in the 12 months prior to the interview, and 6.7% had tested 
positive. 
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404 BENEDIKT FISCHER er al. 
TABLE X Sex and Sex-Related Risks Among Total Opiate User Sample, 1996 (N = 114) 
(N) % 
Unsafe Sex Practices 
Persons who have had unsafe sex in the last 
12 months (N = 113) 
Persons who have had unsafe sex in the last 
12 months with 2 or more different partners (N = 63) 
Persons who have had unsafe sex in the last 12 
months more than one time per week (N = 63) 
63 55.8 
20 31.7 
35 55.6 
Sex-Related Risks 
Hepatitis 
Persons who have ever been tested for: 
(N = 81) Hepatits B or C 75 92.6 
Persons who have ever tested positive for: 
(N = 69) Hepatitis B 19 27.5 
(N = 70) Hepatitis C 39 55.7 
HIV 
Persons who have been tested for HIV 
(N = 99) lifetime 89 89.9 
last year 67 67.7 
6.1 Persons who have ever tested positive for HIV (N = 89) 6 
About one quarter (22.9%) of those who had ever shared a needle 
reported that at some point they had shared a needle with someone they 
knew was HIV positive, and a quarter of these had shared a needle with 
more than one person who was HIV positive. In addition, 10.8% of the 
sample indicated that at some point in their lives, they had had sex with 
someone who was HIV positive or had AIDS, and one third (33.3%) of 
these people reported that they had done so with more than one person. 
Almost one third (30.3%) of the sample reported that, in the year prior to 
the interview, they had “never” been worried about being exposed to the 
HIV virus, while 45.9% said that they had worried “rarely” or “some- 
times”, and 23.9% said that this was the case “often” or “always”. Three 
quarters (73.8%) stated that they had “always” refused to share needles for 
the fear of infection risks, and 54.7% had “always” refused to have unsafe 
sex for these reasons. However, 75.0% of the sample had “never” worried 
about the possibility of giving HIV to someone else. 
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ILLICIT OPIATES IN TORONTO 405 
Crime and criminal justice issues 
Due to the definition of non-prescribed opiates as illicit drugs in the Cana- 
dian context, all of the sample had possessed and used illegal drugs in the 
past month. In fact, 67.5% of the sample self-reported that they had been 
involved directly in illegal drug market or supply activity in the past 
30 days (not including the simple possession of an illegal drug). The mean 
number of illegal activity days, for that period for the people involved in 
these drug market activities, was 17.8. They indicated that they had 
engaged in a mean number of 50.9 such incidents in the 30 days prior to 
the interview. Specifically; 36.0% had committed shoplifting or minor 
theft, with a mean number of activity days of 12.4 (mean number of inci- 
dents: 25.8); 15.8% of the total sample had engaged in break and enters 
(B&Es), theft, and theft from or of cars, on a mean number of 7.4 activity 
days (mean number of incidents: 16.0); 14.0% had committed fraud or for- 
gery, on a mean number of 6.4 activity days (mean number of incidents: 
8.7); and two individuals in the sample had committed robbery. 
Overall, 46.5% of the sample had been involved in some property-type 
offense (not including drug or drug market offenses) in the previous 
30 days. On average, they had engaged in at least one of these offences for 
14.1 of the previous 30 days. 
Those opiate users who had participated in drug market supply activities 
reported an average income of $1,070 for the previous 30 days from these 
activities. Those who participated in property related criminal activities 
reported an average income of $1,341 from such activities for the last 
30 days. The average illegal income, for those who had engaged in illegal 
activity in the 30 days prior to the interview, was $1,780. 
Almost the entire sample (93.9%) had been arrested at least once in their 
lifetime. In fact, 59.8% of those arrested had been arrested 10 or more 
times. The mean number of arrests, for those who had ever been arrested, 
was 38.2. In addition, most ( :9.7%) of those who had ever been arrested 
said that the majority of these arrests were for illegal activities either 
related to their drug use or for involvement in activities in which they were 
trying to get drugs or to get money with which to buy drugs. 
In the 12 month period prior to the interview, 13.1% of the sample had 
been arrested for a drug offense, 38.3% had been arrested for a property type 
of offense, and 13. I % had been involved in or arrested for a capital offense 
(including assault, weapons, arson, manslaughter or murder offences). 
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406 BENEDIKT FISCHER er al. 
TABLE XI History of Involvement with Clininal Justice System Among Total Opiate User 
Sample, 1996 (N = 114) 
(N) Q 
Arrest History - Lifetime 
Persons arrested in their lifetime 
Average number of arrests in lifetime (N = 107) 
AVG 38.2 
SD 103.5 
Arrest History - Last 12 Months 
Persons arrested in the last year for: (N = 107) 
Property offense 
Drug offense 
Capital offense 
Incarceration - Last 12 Months 
Persons who spent time in jail or prison in last 12 months 
Persons who spent more than 20 days in jail or prison in 
last 12 months (N = 48) 
Current Legal Status 
Persons currently under criminal justice system supervi- 
sion 
107 93.9 
41 38.3 
14 13.1 
14 13.1 
48 42.1 
33 68.8 
54 41.4 
In terms of incarceration, 42.1% of the total sample had spent time in 
prison in the 12 months prior to the interview. In fact, three of ten people 
in the overall sample (28.9%), or over two thirds (68.8%) of those who 
had been incarcerated in the past year, had spent 20 days or more in prison 
in that time period. The mean number of days spent in prison in the previ- 
ous 12 months, of those who had been incarcerated in that period, was 
83.6 (35.2 for total sample). 
About half (52.6%) of the total sample reported that they had no current 
active involvement with the criminal justice system at the time of the inter- 
view (not including criminal records). The remaining 47.4% of the sample 
was either in jail, on probation or parole or bail, or awaiting charges or a 
conviction. 
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ILLICIT OPIATES IN TORONTO 407 
Opiate substitutiodtreatment 
More than four out of five opiate users (89.5%), reported that they had, at 
some point in their opiate use careers, taken a significant break from opiate 
use. Of those who had ever stopped, more than half (52.9%) had done so 
5 times or more. 
TABLE XI1 Drug Treatment of Total Opiate User Sample, 1996 (N = 114) 
(N) % 
Drug Treatment History 
Persons who have ever been in a treatment program for 
drug or alcohol use 
Use of Institutional Treatment 
Persons who have ever been in an institutional treatment 
program (N = 67) 
Persons who have ever been is an institutional treatment 
program 2 or more times (N = 29) 
Use of Methadone Treatment 
Persons who have ever been in a methadone treatment 
program (N = 67) 
Persons who have ever been in a methadone treatment 
program 2 or more times (N = 18) 
Anticipated Future Use of Methadone Services 
If offered a spot on a methadone treatment program 
today. persons who would: (N = 89) 
Accept 
Decline 
Undecided 
67 59.3 
29 43.3 
12 41.4 
18 26.9 
4 22.2 
43 48.3 
29 32.6 
17 19.1 
In terms of treatment, the majority (59.3%) of the sample had been in a 
drug or alcohol treatment program at some point in their lives. Less than 
half (43.3%) of this treatment sub-sample had been in institutional 
(in-patient) treatment, and 41 .l% of this latter group had been in institu- 
tional treatment twice or more times in their lives. One quarter (26.9%) of 
A
dd
ic
t R
es
 T
he
or
y 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ita
et
 Z
ue
ric
h 
on
 0
8/
04
/1
4
Fo
r p
er
so
na
l u
se
 o
nl
y.
408 BENEDlKT FISCHER et al. 
the sub-sample with a treatment history had been in a methadone substitu- 
tion program at some point in their lives, and again about one quarter of 
these had been in such a program on two or more separate occasions. 
Half of the former methadone patients in the study sample reported that 
they had been in methadone treatment for six months or less, and the 
majority of these (60.0%) also rated the effects of these programs as either 
“fair” or “poor”. More than one third of the sample (34.7%) reported that 
they had incidents in their lives where they actively sought professional 
help for their drug use, but were not able to find it, and close to half 
(47.4%) had at times looked for or used peer support for their drug use. 
The study sample presents a rather divided and ambiguous attitude 
towards methadone substitution treatment. When asked what they would 
do if they were offered a spot in a methadone program today, about half 
(48.3%) of the sample examined unequivocally said that they would 
accept such a treatment spot. However, about one third (32.6%) of 
respondents clearly rejected this substitution option, while the remaining 
opiate users were undecided or felt ambivalently about it. 
CONCLUSION 
This study presents a comprehensive account of current risks and harms 
experienced by an untreated sample of opiate users in Metropolitan 
Toronto. The findings pose some considerable implications for program- 
ming and further research around untreated opiate use in Toronto and else- 
where, while many of them confirm data that have come out of recent 
opiate user studies conducted in other jurisdictions, mostly European. 
One fundamental caveat which has major implications, not only for the 
generalizability of these findings, but also for further research, must be 
made about the sampling design of this study. The study sample was pri- 
marily recruited at needle exchanges and social service agencies catering 
to the injection drug using population in Toronto. Because of where they 
were recruited, we assume that this opiate user sample is relatively con- 
scious of heath risks and harms related to injection drug use, and does not 
exist in a completely isolated and secluded context, although it has, for 
various reasons, chosen to or not found its ways into the treatment system. 
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ILLICIT OPIATES IN TORONTO 409 
Thus, the sample is likely not representative of the entire opiate using pop- 
ulation in Toronto. 
In fact, the estimates of opiate users for Metro Toronto, when subtracting 
the opiate users who are in  methadone maintenance or other treatment, 
plus the ones who are regularly embraced by the peripheral health and 
social service providers, suggest that there must be a much more “hidden 
population” of opiate users out there that has not been studied in any detail 
yet (Kiibler and Hauser 1997, Watters and Biernacki 1989). The character- 
istics of this remaining “underground scene” may look very different, and 
should be subject to further study. This “basic health care” environment in 
which the study sample was found and located may explain one of the key 
study findings, specifically that the study sample is relatively “healthy”. 
However, this encouraging piece of data from a public health perspective 
may not be the case for the rest of the population of “untreated” opiate 
users in Toronto. 
One of the key health indicators, the HIV and Hepatitis prevalence rates 
found in the sample not only indicate that this study has been dealing with 
a relatively healthy sample, but also that Toronto may have a unique 
chance of preventing a dramatic HIV epidemic among opiate IDUs if 
effective measures are taken immediately. Recent data from Montreal and 
Vancouver indicate that Canadian opiate user scenes are not at all immune 
to epidemics of these infectious diseases, and suggest that such an epi- 
demic will occur in Toronto as well, if pragmatic and effective public 
health oriented measures are not put into place or dramatically expanded 
(Health Canada 1997, Strathdee et al. 1997, Fischer and Rehm 1997). 
Related to this, however, are the discrepancies between perceived health 
risks of the sample and the actual behaviours in which they engage. While 
the sample reports high levels of concern and awareness around health and 
infection risk factors, their reported behaviours (e.g., high rates of needle 
sharing) suggest that these concerns do not readily translate into less risky 
behaviour. Again, it must be made clear that with the health and infection 
risk patterns displayed, infection levels have probably stayed at relatively 
low prevalence levels due to low baseline levels. However, as soon as the 
number of infected agents in the user sample rises, the risk behaviours 
shown suggest that infections may likely spread exponentially. 
On the other hand, despite their relatively healthy status, the data also 
underlined the fact that illicit opiate users are confronted with major obsta- 
cles in receiving the basic health care that they desperately need. The high 
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rates of overdose that are not medically cared for, the number of medical 
problems or treatment requests that were not addressed by the health care 
system make it clear that there are major barriers that need to be overcome 
in order to reduce opiate use-related harms and costs in the future. Such 
public health measures must also note the fact that opiate users in Toronto, 
unlike many European and American jurisdictions where heroin snorting 
and smoking have become increasingly popular, still primarily rely on 
injection for their opiate use. At the same time, there is also a high preva- 
lence for the use of other drugs, especially cocaine and benzodiazepines, 
which may form more harmful drug combinations and effects together 
with opiate substances. Latest trends even indicate an accelerated shift to 
cocaine injection habits in IDU populations. 
The primary source of income for the opiate users sampled in the 
Toronto study is through illegal activities, partly in the form of 
income-generating property crime and partly in the form of small-scale 
drug dealing and drug market activities. This finding has two major impli- 
cations. First, it seems to confirm Grapendaal’s theory which states that 
the level of illegal income generating activities with drug addicts is 
inversely related to the degree of extensiveness of the welfare system sur- 
rounding the drug user (Grapendaal 1992, Bretteville-Jensen and Sutton 
1996). The majority of the opiate users studied in Toronto also rely on wel- 
fare benefits for income generation, but the benefits and amounts seem 
insufficient to cover the expenses required. 
Second, however, these results have implications for “harm reduction” 
policy making targeted at opiate addicts. The data present more confirma- 
tory evidence that the rather artificial and theoretical division between 
“supply” and “demand” side, or users and sellers, among opiate users does 
not hold in practice. In fact, the majority of the opiate users in this sample 
studied are involved in small-scale dealing for income generation as well. 
While some policy makers, as a “harm reduction” measure, have sug- 
gested a removal and shift of “drug possession” (“demand”) from the 
jurisdiction of police and courts to the health care or treatment system 
through treatment orders, diversion programs etc. (Health Canada 1997), 
on the basis of our data it must be recognized that under the current cir- 
cumstances surrounding illicit opiate use in Toronto, small-scale drug mar- 
ket activities constitute a real and functional part of the opiate user’s daily 
life and existence. Thus, if policy makers intend to remove the Toronto 
opiate addict from the revolving cycle of the criminal justice system, 
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income-generating small-scale drug market (and property crime) activities 
must be acknowledged as a concommitant of opiate addiction. Thus, prag- 
matically and effectively shifting the opiate addict away from criminal 
stigma and punishment to social and health services cannot work in prac- 
tice if criminal punishment continues to focus on the primary ways 
through which opiate addicts in Toronto acquire their existential living 
expenses (which include considerable expenses for drugs). As long as opi- 
ate addicts in Toronto are forced to acquire their opiate drugs from illicit 
sources dealing on black market dynamics, illegal sources of income will 
have to remain the prime vehicle for addicts to acquire the daily funds 
needed to survive. A solution for the considerable opiate drugshime 
problem in Toronto thus needs to come to grips with the fact that there is a 
demand for opiate drugs, and if this demand is not dealt with from a public 
health perspective, consequences for society at large, as well as the opiate 
users themselves, will be harmful and costly. All other assumptions would 
be based on unempirical speculation and distance from the opiate user’s 
reality. 
For further and more long-term reduction of social harms and risks asso- 
ciated with illicit opiate use, this study provides another important finding 
with regards to the necessary and appropriate “continuum of care” for 
these opiate user populations. While methadone substitution has been 
more widely introduced and made substantially more accessible to the opi- 
ate user population in the Toronto context over the past couple of years, 
and has been hailed by many as the ultimate form of treatment for opiate 
users, these data clearly show that MMT has its limits as a treatment 
option for the opiate user population as a whole (see also Uchtenhagen et 
al. 1995, Nadelmann et al. 1997, Fischer and Rehm 1997). The fact that 
only half of the users sampled in this study consider MMT as a treatment 
option for themselves will require further analysis of qualitative data col- 
lected on why methadone is seen to be of such limited value as a substitu- 
tion treatment for this group of drug users. Some of it may have to do with 
past negative experiences in the MMT realm, others may not like the idea 
of substitution in general, the procedures and forms of application, or the 
substance itself and its pharmacological effects. However, these findings 
also indicate that, if further substantial social and physical harms and 
related costs are to be prevented, there is a dire need in the Toronto setting 
to establish and expand a much wider “continuum of care” for illicit opiate 
use, that for once should also include a much broader, more diverse and 
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more user-oriented spectrum of substitution substances and procedures 
than the ones practised currently. Other jurisdictions have made much 
headway in this regard over the past few years, and have much positive 
experience to offer. 
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